In the wake of the increase in Current Liabilities in the second quarter 2026, Quick Ratio fell to 2.13 below Butterfly Network Inc average.

Within Medical Laboratories industry 16 other companies have achieved higher Quick Ratio than Butterfly Network Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 1058 to 1222.

Explain Quick Ratio?
How much Cash & cash equivalents BFLY�s has?
What are BFLY�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

BFLY Quick Ratio	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3	(Jun 30 2025) Q2
Y / Y Current Liabilities Change	175.8 %	33.19 %	213.77 %	137.66 %	5.15 %
Y / Y Cash & cash equivalent Change	-15.85 %	-11.12 %	69.52 %	53.84 %	45.16 %
Quick Ratio MRQ	2.13	5.08	2.23	2.87	6.97
BFLY's Total Ranking	# 1222	# 1058	# 663	# 821	# 91
Seq. Current Liabilities Change	115.83 %	-59.83 %	34.3 %	136.87 %	4.22 %
Seq. Cash & cash equivalent Change	-9.64 %	-8.33 %	4.34 %	-2.63 %	-4.56 %

Quick Ratio second quarter 2026 Company Ranking
Within:	No.
Medical Laboratories Industry	# 17
Healthcare Sector	# 488
Overall Market	# 1222

Quick Ratio Statistics
High	Average	Low
65.58	9.81	0.06
(Mar 31 2022)		(Sep 30 2012)

Financial Statements
Butterfly Network Inc 's Current Liabilities	$ 59 Millions	Visit BFLY's Balance sheet
Butterfly Network Inc 's Cash & cash equivalent	$ 125 Millions	Visit BFLY's Balance sheet
Source of BFLY's Sales		Visit BFLY's Sales by Geography

Cumulative Butterfly Network Inc 's Quick Ratio

BFLY's Quick Ratio for the trailling 12 Months

BFLY Quick Ratio	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months	(Jun 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	141.46 %	99.63 %	90.01 %	35.17 %	-2.98 %
Y / Y Cash & cash equivalent TTM Growth	14.71 %	32.06 %	50.56 %	21.1 %	-2.66 %
Quick Ratio TTM	2.74	3.49	3.75	4.73	5.76
Total Ranking TTM	# 3893	# 3808	# 2177	# 643	# 2282
Seq. Current Liabilities TTM Growth	22.46 %	4.24 %	40.57 %	34.56 %	1.25 %
Seq. Cash & cash equivalent TTM Growth	-4.04 %	-2.89 %	11.51 %	10.39 %	10.48 %

Quick ratio ranking by company, industry and sector >> Back to BFLY Financial Strength Comparisons >> Go to Compare BFLY Quick Ratio to its Competitors

On the trailing twelve months basis Due to in Current Liabilities in the Q2 2026 to $58.60 millions, cumulative Quick Ratio decreased to 2.74 below the Butterfly Network Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Laboratories industry 34 other companies have achieved higher Quick Ratio than Butterfly Network Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 3808 to 3893.

Explain Quick Ratio?
How much Cash & cash equivalents BFLY�s has?
What are BFLY�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Laboratories Industry	# 35
Healthcare Sector	# 886
Within the Market	# 3893

trailing twelve months Quick Ratio Statistics
High	Average	Low
9.48	3.44	0.11
(Dec 31 2021)		(Sep 30 2012)

Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Laboratories Industry	Quick Ratio	Jun 30 2026 MRQ Cash & cash equivalent	Jun 30 2026 MRQ Current Liabilities
Castle Biosciences Inc	4.72	$ 266.805 Millions	$ 56.509 Millions
Bionexus Gene Lab Corp	4.33	$ 3.522 Millions	$ 0.813 Millions
Caredx Inc	3.99	$ 373.636 Millions	$ 93.698 Millions
Omniab Inc	3.78	$ 51.995 Millions	$ 13.758 Millions
Fulgent Genetics Inc	3.58	$ 257.032 Millions	$ 71.756 Millions
Guardant Health Inc	3.11	$ 1,053.469 Millions	$ 338.962 Millions
Butterfly Network Inc	2.13	$ 124.659 Millions	$ 58.603 Millions
Natera Inc	1.97	$ 1,091.502 Millions	$ 553.200 Millions
Biodesix Inc	1.96	$ 29.996 Millions	$ 15.291 Millions
Sera Prognostics Inc	1.91	$ 46.445 Millions	$ 24.356 Millions
Exagen Inc	1.83	$ 24.588 Millions	$ 13.457 Millions
Radnet Inc	1.11	$ 773.510 Millions	$ 697.822 Millions
Bioaffinity Technologies Inc	0.91	$ 2.430 Millions	$ 2.681 Millions
Ispecimen inc	0.43	$ 4.426 Millions	$ 10.196 Millions

Date modified: 2026-09-12T18:15:39+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.